Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13–18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prediabetes has been found to be associated with decreased heart rate variability61 (HRV – a marker of parasympathetic function),62–65, decreased postural changes in heart rate,62 increased prevalence of erectile dysfunction among men,66 and a worse profile in tests of sympathetic and parasympathetic function.67”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic neuropathy (distal symmetric polyneuropathy (DSPN)) causes bilateral decrease or loss of ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“These criteria include obvious bilateral loss or reduction of the ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“No consistent evidence is available to suggest that prediabetes is associated with measurements of orthostatic blood pressure changes,63 which is a late marker of diabetic neuropathy,61 or with decreased expiratory-inspiratory ratio or change in heart rate during breathing.63”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationDyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482 · cited 3×
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety (1).”
BackgroundSelf-citationVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 3×
“Some pathogenetic mechanisms may link CAN to cardiovascular dysfunction and diabetic complications (34).”
BackgroundInfluentialSelf-citationGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913 · cited 3×
“The symptoms are distal, symmetrical, often associated with nocturnal exacerbations, and commonly described as prickling, deep aching, sharp, like an electric shock, and burning (13) with hyperalgesia and frequently allodynia upon examination (17).”
BackgroundInfluentialSelf-citationLauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Self-citation
Research works printed but not linked: 1
- Appell, 1991, DM and Other Peripheral Neuropathies Affecting Lower Urinary Tract Function, 365
Cited by
Items 201–300 of 1,002
Painful and Painless Diabetic Neuropathy: One Disease or Two?
Spallone, V., & Greco, C. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0387-7 · Cited by 99
Self-citationVinik, A. I., Smith, A. G., Singleton, J. R., Callaghan, B. C., Freedman, B. I., Tuomilehto, J. O., Bordier, L., Bauduceau, B., & Roche, F. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0396 · Cited by 96
Self-citationLiu, S., Zheng, H., Zhu, X., Mao, F., Zhang, S., Shi, H., Li, Y., & Lü, B. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.008 · Cited by 92
Binns-Hall, O., Selvarajah, D., Sanger, D. M., Walker, J., Scott, A., & Tesfaye, S. H. (2018) · Diabetic Medicine · doi:10.1111/dme.13630 · Cited by 101
Self-citationTrial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations
Gewandter, J. S., Brell, J. M., Cavaletti, G., Dougherty, P. M., Evans, S. R., Howie, L. J., McDermott, M., O’Mara, A. M., Smith, A. G., Dastros-Pitei, D., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006083 · Cited by 103
“One approach could be to exclude patients who have probable preexisting neuropathy but include patients with possible preexisting neuropathy as defined by the Toronto Diabetic Neuropathy Expert Group.(9) For studies in which a neurologist is not available at all sites, this would require standardizing neurologic asses…”
BackgroundSelf-citationIdiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria
Freeman, R. L., Gewandter, J. S., Faber, C. G., Gibbons, C. H., Haroutounian, S., Lauria, G., Levine, T., Malik, R. A., Singleton, J. R., Smith, A. G., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010988 · Cited by 98
Self-citationMochizuki, Y., Tanaka, H., Matsumoto, K., Sano, H., Toki, H., Shimoura, H., Ooka, J., Sawa, T., Motoji, Y., Ryo, K., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0201-8 · Cited by 102
“Experienced diabetologists assessed the presence of diabetic neuropathy according to current guidelines and with reference to a nerve conduction study [25].”
MethodTreating Diabetic Neuropathy: Present Strategies and Emerging Solutions
Javed, S., Alam, U., & Malik, R. A. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.63 · Cited by 101
“DAN is typically diagnosed through the assessment of the signs and symptoms attributable to the dysfunction of a particular organ system [8].”
BackgroundInfluentialSelf-citationCorneal Confocal Microscopy to Assess Diabetic Neuropathy: An Eye on the Foot
Tavakoli, M., Petropoulos, I. N., & Malik, R. A. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700509 · Cited by 91
Self-citationEdwards, C., & Cusi, K. J. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.007 · Cited by 120
Whither pathogenetic treatments for diabetic polyneuropathy?
Boulton, A. J. M., Kempler, P., As, A., & Ziegler, D. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2397 · Cited by 93
“In the absence of controlled trials, surgical nerve decompression cannot be recommended as a routine treatment option [7,24].”
BackgroundMethodSelf-citationAssociation of Subclinical Inflammation With Polyneuropathy in the Older Population
Herder, C., Bongaerts, B. W. C., Rathmann, W., Heier, M., Kowall, B., Köenig, W., Thorand, B., Roden, M., Meisinger, C., & Ziegler, D. (2013) · Diabetes Care · doi:10.2337/dc13-0382 · Cited by 94
“Moreover, our definition of DSPN only satisfies the minimal diagnostic criteria for possible DSPN, not for probable or confirmed DSPN, according to the Toronto Diabetic Neuropathy Expert Group (1), and also corresponds to the lowest likelihood of DSPN according to the report of the American Academy of Neurology (40).”
BackgroundPulmonary Function and Sleep Breathing: Two New Targets for Type 2 Diabetes Care
Lecube, A., Simó, R., Pallayová, M., Punjabi, N. M., López‐Cano, C., Turino, C., Hernández, C., & Barbé, F. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00173 · Cited by 100
Yotsu, R. R., Pham, N. M., Oe, M., Nagase, T., Sanada, H., Hara, H., Fukuda, S., Fujitani, J., Yamamoto‐Honda, R., Kajio, H., et al. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.013 · Cited by 96
“Assessments of peripheral neuropathy were performed based on these findings, as previously described (Tesfaye et al., 2010).”
MethodDiabetic Neuropathy: Pathophysiology Review
Strand, N. H., Anderson, M. A., Attanti, S., Gill, B., Wie, C. S., Dawodu, A., Pagan-Rosado, R. D., Harbell, M. W., & Maloney, J. A. (2024) · Current Pain and Headache Reports · doi:10.1007/s11916-024-01243-5 · Cited by 110
“…symptoms–decreased sensation, positive neuropathic sensory symptoms (e.g., “asleep numbness,” prickling or stab-bing, burning or aching pain) predominantly in the toes, feet, or legs; or signs–symmetric decrease of distal sensation or unequivocally decreased or absent ankle reflexes” [36].”
InfluentialSalvotelli, L., Stoico, V., Perrone, F., Cacciatori, V., Negri, C., Brangani, C., Pichiri, I., Targher, G., Bonora, E., & Zoppini, G. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.06.014 · Cited by 91
“The most common among diabetic neuropathies is the peripheral sensorimotor form, that is symmetrical, chronic and length-dependent (Tesfaye et al., 2010).”
BackgroundIdentifying Common Genetic Risk Factors of Diabetic Neuropathies
Witzel, I., Jelinek, H. F., Khalaf, K. A., Lee, S., Khandoker, A. H., & AlSafar, H. S. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00088 · Cited by 103
“Early subclinical detection of diabetic neuropathy, by assessing genetic predisposition as well as metabolic control and physiology of diabetic patients, is critical in facilitating early intervention and prevention of the potentially serious consequences of diabetic neuropathy (5, 6).”
BackgroundInfluentialImpaired Glycemia and Diabetic Polyneuropathy
Dyck, P. J. B., Clark, V. M., Overland, C. J., Davies, J. L., Pach, J. M., Dyck, P. J. B., Klein, C. J., Rizza, R. A., Melton, L. J., Carter, R. E., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1421 · Cited by 99
Self-citationRecent Advances in Diagnostic Strategies for Diabetic Peripheral Neuropathy
Won, J. C., & Park, T. S. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.230 · Cited by 92
Smith, A. G., & Singleton, J. R. (2012) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000411568.34085.3e · Cited by 95
GLP‐1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice
Jolivalt, C. G., Fineman, M., Deacon, C. F., Carr, R. D., & Calcutt, N. A. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01431.x · Cited by 87
Clinical diagnosis and management of small fiber neuropathy: an update on best practice
Devigili, G., Cazzato, D., & Lauria, G. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1794825 · Cited by 101
“AC CE PT ED MA NU SC RI PT Diabetes accounts for about 20% of cases, but the prevalence increases if impaired fasting glucose (IFG) and oral glucose tolerance test (OGTT) are included [46,47].”
MethodInfluentialSelf-citationEtiology, pathophysiology and classifications of the diabetic Charcot foot
Παπάνας, Ν., & Maltezos, E. S. (2013) · Diabetic Foot & Ankle · doi:10.3402/dfa.v4i0.20872 · Cited by 87
“hyperglycemia and microvascular disease, leading to nerve injury via osmotic changes and ischemia, respectively (8).”
BackgroundCardiac Autonomic Neuropathy: Why Should Cardiologists Care about That?
Bissinger, A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/5374176 · Cited by 103
“Cardiovascular sympathetic function is assessed by measuring the BP response to orthostatic change and a Valsalva maneuver [47].”
BackgroundRetinal nerve fibre layer thinning associated with diabetic peripheral neuropathy
Shahidi, A. M., Sampson, G. P., Pritchard, N., Edwards, K. P., Vagenas, D., Russell, A. W., Malik, R. A., & Efron, N. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03588.x · Cited by 86
Self-citationToosizadeh, N., Mohler, J. M., Armstrong, D. G., Talal, T. K., & Najafi, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135255 · Cited by 98
Hoeijmakers, J. G. J., Han, C., Merkies, I. S. J., Macala, L. J., Lauria, G., Gerrits, M. M., Dib‐Hajj, S. D., Faber, C. G., & Waxman, S. G. (2012) · Brain · doi:10.1093/brain/awr349 · Cited by 91
Self-citationCiccacci, C., Morganti, R., Fusco, D. D., D’Amato, C., Cacciotti, L., Greco, C., Rufini, S., Novelli, G., Sangiuolo, F. C., Marfia, G. A., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0582-2 · Cited by 89
Self-citationClinical neuropathy scales in neuropathy associated with impaired glucose tolerance
Zilliox, L. A., Ruby, S. K., Singh, S., Zhan, M., & Russell, J. W. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.01.011 · Cited by 85
“jdiaco The presence of neuropathy was determined using criteria for confirmed diabetic sensorimotor polyneuropathy according to guidelines published by the Toronto Diabetic Neuropathy Expert Group (Tesfaye et al., 2010).”
BackgroundMethodInfluentialTruini, A., Spallone, V., Morganti, R., Tamburin, S., Zanette, G., Schenone, A., De Michelis, C., Tugnoli, V., Simioni, V., Manganelli, F., et al. (2018) · Pain · doi:10.1097/j.pain.0000000000001378 · Cited by 85
Self-citationChen, X., Graham, J., Petropoulos, I., Ponirakis, G., Asghar, O., Alam, U., Marshall, A., Ferdousi, M., Azmi, S., Efron, N., et al. (2018) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.17-23342 · Cited by 80
“All subjects were assessed for the presence and severity of DSPN based on the updated Toronto consensus criteria.(33)All participants underwent assessment of body mass index, glycated hemoglobin (HbA1c), total cholesterol, high-density lipoprotein cholesterol (HDL), triglycerides, and systolic and diastolic blood pres…”
MethodSelf-citationMundinger, T. O., Mei, Q., Foulis, A. K., Fligner, C. L., Hull, R. L., & Taborsky, G. J. (2016) · Diabetes · doi:10.2337/db16-0284 · Cited by 86
Puchałowicz, K., & Rać, M. E. (2020) · Cells · doi:10.3390/cells9081877 · Cited by 97
Neuropathic Pain: Is Quantitative Sensory Testing Helpful?
Krumova, E. K., Geber, C., Westermann, A., & Maier, C. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0282-7 · Cited by 100
Aguíar, C., Alegría, E., Bonadonna, R. C., Catapano, A. L., Cosentino, F., Elisaf, M., Farnier, M., Ferrières, J., Filardi, P. P., Hâncu, N., et al. (2015) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(15)30001-5 · Cited by 90
Self-citationD’Amato, C., Morganti, R., Greco, C., Di Gennaro, F., Cacciotti, L., Longo, S., Mataluni, G., Lauro, D., Marfia, G. A., & Spallone, V. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116653240 · Cited by 83
Self-citationA simple new non‐invasive sweat indicator test for the diagnosis of diabetic neuropathy
Παπάνας, Ν., Boulton, A. J. M., Malik, R. A., Manes, C., Schnell, O., Spallone, V., Tentolouris, N., Tesfaye, S. H., Valensi, P. E., Ziegler, D., et al. (2012) · Diabetic Medicine · doi:10.1111/dme.12000 · Cited by 92
Self-citationWang, D. D., Bakhotmah, B. A., Hu, F. B., & Alzahrani, H. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106935 · Cited by 95
“Previous studies [3,4,5] and clinical guidelines [1,26] have indicated aggressive blood glucose control as a standard clinical practice in the management of DPN.”
BackgroundYajnik, C. S., Kantikar, V., Pande, A. J., Deslypère, J. P., Dupin, J., Calvet, J., & Bauduceau, B. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.09.004 · Cited by 83
Lupachyk, S., Shevalye, H., Maksimchyk, Y., Drel, V. R., & Obrosova, I. G. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.037 · Cited by 82
“Diabetic peripheral neuropathy (DPN) affects at least 50% of diabetic subjects with both type 1 and type 2 diabetes mellitus in the United States and is the leading cause of foot amputation [1–4].”
BackgroundDiagnostic opportunities based on skin biomarkers
Paliwal, S., Hwang, B. H., Tsai, K. Y., & Mitragotri, S. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.009 · Cited by 85
“bers (Tesfaye et al., 2010)”
BackgroundVenkataraman, K., Tai, B. C., Khoo, E. Y. H., Tavintharan, S., Chandran, K., Hwang, S. W., Phua, M. S. L. A., Wee, H. L., Koh, G. C. H., & Tai, E. S. (2019) · Diabetologia · doi:10.1007/s00125-019-04979-7 · Cited by 81
Williams, K. J., & Wu, X. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.004 · Cited by 87
Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis
Shiferaw, W. S., Akalu, T. Y., Work, Y., & Aynalem, Y. A. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0534-5 · Cited by 81
Li, C., Wang, W., Ji, Q., Ran, X., Kuang, H., Yu, X., Fang, H., Yang, J., Liu, J., Xue, Y., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110602 · Cited by 91
Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy: A Randomized Clinical Trial
The Vitamin E in Neuroprotection Study (VENUS) Investigators, Hor, C. P., Fung, W.-Y., Ang, H. A., Lim, S. C., Kam, L. Y., Sim, S.-W., Lim, L. H., Choon, W. Y., Wong, J. W., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4609 · Cited by 87
Update on the management of diabetic polyneuropathies
Stevens, M. J., & Shakher, J. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s11324 · Cited by 103
“The most frequent location of pain has been reported to be as follows: 96% feet, 69% balls of feet, 67% toes, 54% dorsum of foot, 39% hands, 37% plantum of foot, 37% calves, and 32% heels.(17) In extreme cases, patients may experience hypoalgesia and allodynia when even the lightest of touch can provoke perception of…”
Merola, A., Romagnolo, A., Zibetti, M., Bernardini, A., Cocito, D., & Lopiano, L. (2015) · European Journal of Neurology · doi:10.1111/ene.12846 · Cited by 79
“Peripheral neuropathy was defined as symmetric alteration of nerve conduction studies action potential amplitudes and/or velocities in at least two motor and/or sensory nerves according to the reference values provided by Kimura [15], accompanied by signs/ symptoms of peripheral nervous system involvement [16].”
MethodPai, Y., Lin, C., Lee, I., & Chang, M. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.09.013 · Cited by 78
Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes
Ishibashi, F., Taniguchi, M., Kosaka, A., Uetake, H., & Tavakoli, M. (2018) · Diabetes Care · doi:10.2337/dc18-1560 · Cited by 82
Evangelista, A. F., Vannier-Santos, M. A., Silva, G. S. D. A., Silva, D. N., Juíz, P. J. L., Nonaka, C. K. V., dos Santos, R. R., Soares, M. B. P., & Villarreal, C. F. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1224-3 · Cited by 80
Mesinovic, J., McMillan, L. B., Shore‐Lorenti, C., de Courten, B. V., Ebeling, P. R., & Scott, D. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020145 · Cited by 81
“Impaired glycaemic control can result in peripheral neuropathy [9], myopathy [10] and inflammation [11], and both dyslipidaemia and hypertension can lead to microand macro-vascular complications [12,13].”
BackgroundBheereddy, P., Yerra, V. G., Kalvala, A. K., Sherkhane, B., & Kumar, A. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00923-1 · Cited by 80
Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy
Geerts, M., de Greef, B. T. A., Sopacua, M., van Kuijk, S. M. J., Hoeijmakers, J. G. J., Faber, C. G., & Merkies, I. S. J. (2021) · Neurology · doi:10.1212/wnl.0000000000011919 · Cited by 78
Gong, H., Ren, Y., Li, Z., Zha, P., Bista, R., Li, Y., Chen, D., Gao, Y., Chen, L., Ran, X., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1144806 · Cited by 98
Prevalence of diabetic peripheral neuropathy in Iran: a systematic review and meta-analysis
Sobhani, S., Asayesh, H., Sharifi, F., Djalalinia, S., Baradaran, H. R., Arzaghi, S. M., Mansourian, M., Rezapoor, A., Ansari, H., Parvaresh‐Masoud, M., et al. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-014-0097-y · Cited by 80
“It develops on (or with) a background of long-standing hyperglycemia, associated metabolic derangements (increased polyol flux, accumulation of advanced glycation end products, oxidative stress, and lipid alterations among other metabolic abnormalities) and cardiovascular risk factors [10,11].”
BackgroundThe contributors of emotional distress in painful diabetic neuropathy
Selvarajah, D., Cash, T., Sankar, A., Thomas, L., Davies, J., Boland, E. G., Gandhi, R. A., Wilkinson, I. D., Wilkinson, N., Emery, C., et al. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114522135 · Cited by 84
Self-citationBönhof, G. J., Strom, A., Püttgen, S., Ringel, B., Brüggemann, J., Bódis, K. B., Müssig, K., Szendroedi, J., Roden, M., & Ziegler, D. (2017) · Diabetologia · doi:10.1007/s00125-017-4438-5 · Cited by 76
Yield of peripheral sodium channels gene screening in pure small fibre neuropathy
Eijkenboom, I., Sopacua, M., Hoeijmakers, J. G. J., de Greef, B. T. A., Lindsey, P. J., Almomani, R., Marchi, M., Vanoevelen, J. M., Smeets, H. J. M., Waxman, S. G., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319042 · Cited by 81
Self-citationKonieczyńska, M., Fil, K., Bazanek, M., & Undas, A. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0566 · Cited by 80
“Diabetic neuropathy was diagnosed according to the Toronto Diabetic Neuropathy Expert Group definition (22).”
MethodSpinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy
Marshall, A. G., Lee-Kubli, C. A., Azmi, S., Zhang, M., Ferdousi, M., Mixcoatl-Zecuatl, T., Petropoulos, I. N., Ponirakis, G., Fineman, M. S., Fadavi, H., et al. (2017) · Diabetes · doi:10.2337/db16-1181 · Cited by 76
Self-citationContact heat evoked potentials: Normal values and use in small‐fiber neuropathy
Lagerburg, V., Bakkers, M., Bouwhuis, A., Hoeijmakers, J. G. J., Smit, A. M., Berg, S. J. M. V. D., Boer, I. H., Lee, M. D. G. B. D., Kranendonk, D., Reulen, J. P. H., et al. (2014) · Muscle & Nerve · doi:10.1002/mus.24465 · Cited by 78
“large-fiber function on examination (normal vibration sense and nerve conduction studies) with abnormal IENFD, and/or abnormal temperature threshold testing (TTT).(4,5) The sensitivity of IENFD for SFN depends largely on the chosen cutoff values,(6) and this technique is not widely available.”
BackgroundGhaznavi, H., Najafi, R., Mehrzadi, S., Hosseini, A., Maroof, N. T., Shakeri‐Zadeh, A., Rezayat, S. M., & Sharifi, A. M. (2015) · Neurological Research · doi:10.1179/1743132815y.0000000037 · Cited by 76
Dietary reversal of neuropathy in a murine model of prediabetes and the metabolic syndrome
Hinder, L. M., O’Brien, P. D., Hayes, J. M., Backus, C., Solway, A. P., Sims‐Robinson, C., & Feldman, E. L. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028530 · Cited by 75
“, 2014) and the Toronto Consensus Criteria (Tesfaye et al., 2010).”
BackgroundMethodDiet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy
Preguiça, I., Alves, A., Nunes, S., Gomes, P., Fernandes, R., Viana, S., & Reis, F. (2020) · Nutrients · doi:10.3390/nu12010250 · Cited by 85
“, prickling, stabbing, and/or burning sensations) is consistently reported, likely reflecting structural small-fiber damage [22,23].”
BackgroundMethodLiu, R., Li, L., Shao, C., Cai, H., & Wang, Z. (2022) · Journal of Diabetes Research · doi:10.1155/2022/1531289 · Cited by 98
“The fi rst category, which is more common, is called typical diabetic peripheral neuropathy (DPN), also known as length-dependent sensorimotor polyneuropathy (DSPN); the second category is atypical DPN, also called polyneuropathy [84].”
BackgroundCiardullo, S., Muraca, E., Bianconi, E., Cannistraci, R., Perra, S., Zerbini, F., & Perseghin, G. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac580 · Cited by 77
Aktaş, G. (2024) · Biomolecules and Biomedicine · doi:10.17305/bb.2024.10426 · Cited by 78
“The diagnosis of DN was based on the recommendations of the Toronto Diabetic Neuropathy Expert Group [10].”
MethodEldabe, S. S., Espinet, A. J., Wåhlstedt, A., Kang, P., Liem, L., Patel, N. K., Vesper, J., Kimber, A., Cusack, W. F., & Kramer, J. M. (2018) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12767 · Cited by 74
Plantar thermography is useful in the early diagnosis of diabetic neuropathy
Balbinot, L. F., Canani, L. H. S., Robinson, C. C., Achaval, M., & Zaro, M. A. (2012) · Clinics · doi:10.6061/clinics/2012(12)12 · Cited by 75
“Electromyography with nerve conduction assessment is the neurophysiological test that confirms the distal symmetric polyneuropathy that is typical of diabetes, and it is the standard protocol in most centers that specialize in neuropathy (6-9).”
BackgroundMethodInfluentialWhich Method for Diagnosing Small Fiber Neuropathy?
Fabry, V., Gerdelat, A., Acket, B., Cintas, P., Rousseau, V., Uro‐Coste, E., Evrard, S., & Traon, A. P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00342 · Cited by 77
“proposed criteria for diabetic SFN (NEURODIAB criteria) with different levels of probability including probable SFN (with clinical criteria associating lengthdependant symptoms, clinical signs of small fiber and normality of nerve conduction on the sural nerve) and definite SNF (requiring an abnormal IENFD and/or an a…”
BackgroundThe prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review
Eleftheriadou, A., Williams, S., Nevitt, S. J., Brown, E. E., Roylance, R., Wilding, J. P. H., Cuthbertson, D. J., & Alam, U. (2020) · Diabetologia · doi:10.1007/s00125-020-05316-z · Cited by 80
Corneal Confocal Microscopy: A Biomarker for Diabetic Peripheral Neuropathy
Petropoulos, I. N., Ponirakis, G., Ferdousi, M., Azmi, S., Kalteniece, A., Khan, A., Gad, H., Bashir, B., Marshall, A. G., Boulton, A. J. M., et al. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.04.003 · Cited by 83
Self-citationSjögren Syndrome-Associated Small Fiber Neuropathy
Sène, D., Cacoub, P., Authier, F., Haroche, J., Créange, A., Saadoun, D., Amoura, Z., Guillausseau, P.-J., & Lefaucheur, J. (2013) · Medicine · doi:10.1097/md.0000000000000005 · Cited by 74
“Some consensus papers are considering IENFD among other techniques, without giving the highest level of evidence for any of the various techniques used for this purpose.(10,56) In fact, compared to QST, IENFD was found to be more sensitive,(9,38,48,52) equally sensitive,(39,55,59) or even less sensitive for the diagno…”
MethodThe clinical approach to autonomic failure in neurological disorders
Benarroch, E. E. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.88 · Cited by 71
Endoplasmic reticulum stress contributes to prediabetic peripheral neuropathy
Lupachyk, S., Watcho, P., Obrosov, A. A., Stavniichuk, R., & Obrosova, I. G. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.001 · Cited by 73
“Diabetic peripheral neuropathy (DPN) affects at least 50% of patients with both Type 1 and Type 2 diabetes, and is a leading cause of foot amputation (Boulton et al., 2005; Sinnreich et al., 2005; Tesfaye et al., 2010; Veves et al., 2008).”
BackgroundAssessing Decreased Sensation and Increased Sensory Phenomena in Diabetic Polyneuropathies
Dyck, P. J. B., Herrmann, D. N., Staff, N. P., & Dyck, P. J. B. (2013) · Diabetes · doi:10.2337/db13-0352 · Cited by 75
Self-citationHeart rate variability - current diagnosis of the cardiac autonomic neuropathy. A review
Metelka, R. (2014) · Biomedical Papers · doi:10.5507/bp.2014.025 · Cited by 85
Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy?
Pérez-Matos, M. C., Alvarez, M. C. M., & Mendivil, C. O. (2017) · Journal of Diabetes Research · doi:10.1155/2017/6943851 · Cited by 88
Preston, F. G., Meng, Y., Burgess, J., Ferdousi, M., Azmi, S., Petropoulos, I. N., Kaye, S., Malik, R. A., Zheng, Y., & Alam, U. (2022) · Diabetologia · doi:10.1007/s00125-021-05617-x · Cited by 70
“Peripheral neuropathy was defined according to the Toronto Consensus on diabetic neuropathy, which defined confirmed diabetic neuropathy as a combination of an abnormality of nerve conduction studies and a symptom(s) and/or sign(s) of neuropathy [27].”
BackgroundMethodSelf-citationDidangelos, T., Karlafti, E., Kotzakioulafi, E., Kontoninas, Z., Margaritidis, C., Giannoulaki, P., & Kantartzis, K. (2020) · Nutrients · doi:10.3390/nu12113254 · Cited by 76
“The following methods were used for detecting DPN and Diabetic Autonomic Neuropathy (DAN): The Michigan Neuropathy Screening Instrument Questionnaire and Examination (MNSIQ and MNSIE) [36,39], measurement of vibration perception threshold with biothesiometer (BIO) (Ohio, USA) [40], and an assessment of large-fiber fun…”
BackgroundInfluentialA Comprehensive Review of Neuronal Changes in Diabetics
Luna, R., Manjunatha, R. T., Bollu, B., Jhaveri, S., Avanthika, C., Reddy, N., Saha, T., & Gandhi, F. R. (2021) · Cureus · doi:10.7759/cureus.19142 · Cited by 93
“5% to 50%, depending on the age period of diabetes and diagnostic criteria [152].”
BackgroundBurning through the pain: treatments for diabetic neuropathy
Javed, S., Alam, U., & Malik, R. A. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12535 · Cited by 78
“Although the exact choice of therapeutic agent differs between organizations, the management approach is built on three basic principles: intensive glycaemic control (although there is limited evidence that this plays a major role in pain modulation); aggressive pain management; and pathogenetic treatment, although th…”
BackgroundMethodInfluentialSelf-citationReduced respiratory muscle strength and endurance in type 2 diabetes mellitus
Fuso, L., Pitocco, D., Longobardi, A., Zaccardi, F., Contu, C., Pozzuto, C., Basso, S., Varone, F., Ghirlanda, G., & Incalzi, R. A. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2284 · Cited by 74
“Group [23].”
Yovera-Aldana, M., Velásquez‐Rimachi, V., Huerta‐Rosario, A., More-Yupanqui, M. D., Osores-Flores, M., Espinoza, R., Gil-Olivares, F., Quispe-Nolazco, C. M., Quea-Vélez, F., Morán‐Mariños, C., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251642 · Cited by 85
“of neuropathy), (c) possible DPN (any symptoms or signs) and (d) subclinical DPN (no signs or symptoms of neuropathy with abnormal nerve conduction test or a validated measure of small fiber neuropathy [34]).”
BackgroundDiabetic Autonomic Imbalance and Glycemic Variability
Fleischer, J. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600526 · Cited by 74
Kwon, B. S., Kim, Y., Lee, S. H., Lim, S. Y., Lee, Y. J., Park, J. S., Cho, Y., Yoon, H. I., Lee, C., & Lee, J. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236109 · Cited by 68
Qiu, L.-T., Xiao, Z., Fan, B., Li, L., & Sun, G. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02238-2 · Cited by 77
Is There a Relationship Between Oral Health and Diabetic Neuropathy?
Borgnakke, W. S., Anderson, P. F., Shannon, C., & Jivănescu, A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0673-7 · Cited by 85
The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy
Bril, V., Blanchette, C. M., Noone, J., Runken, M. C., Gelinas, D. F., & Russell, J. W. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.007 · Cited by 68
Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy
Rolim, L. C., da Silva, E. M., Flumignan, R. L., Abreu, M. M., & Dib, S. A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011265.pub2 · Cited by 71
“Diabetic participants could have any severity of DPN (for example, stages from Grade 0 to Grade 5 described by Dyck 1988) and any of the three definitions of minimal criteria for typical DPN, as recommended by the Toronto Consensus (Tesfaye 2010), that is, probable, confirmed, or subclinical DPN.”
BackgroundMethodInfluentialXiao, Y., Wei, L., Xiong, X., Yang, M., & Sun, L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.564738 · Cited by 72
“), neurologic examinations and the results of nerve conduction tests (29).”
BackgroundCorneal Confocal Microscopy: A New Technique for Early Detection of Diabetic Neuropathy
Παπάνας, Ν., & Ziegler, D. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0390-z · Cited by 68
“Comparison has mainly been against DPN, diagnosed and staged by clinical examination [2], including combinations of signs, quantitative sensory testing and, occasionally, nerve conduction studies [32, 61–63, 66, 69•, 70–72, 75, 76•, 77, 78].”
BackgroundMethodInfluentialDiabetic Autonomic Neuropathy Affects Symptom Generation and Brain-Gut Axis
Brock, C., Søfteland, E. W., Gunterberg, V., Frøkjær, J. B., Lelic, D., Brock, B., Dimcevski, G. G., Gregersen, H. N., Simrén, M., & Drewes, A. M. (2013) · Diabetes Care · doi:10.2337/dc13-0347 · Cited by 67
Effects of insulin on the skin: possible healing benefits for diabetic foot ulcers
Emanuelli, T., Burgeiro, A., & Carvalho, E. (2016) · Archives of Dermatological Research · doi:10.1007/s00403-016-1686-z · Cited by 72
“Diabetic neuropathy is a microvascular complication that affects almost 50 % of all diabetics [142].”
BackgroundHypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00023-7 · Cited by 74
Liu, S.-Y., Chen, L., Li, X., Hu, Q., & He, L. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.12.011 · Cited by 71
Prolonged prothrombotic effects of antecedent hypoglycemia in individuals with type 2 diabetes
Chow, E., Iqbal, A., Walkinshaw, E., Phoenix, F., Macdonald, I. A., Storey, R. F., Ajjan, R., & Heller, S. R. (2018) · Diabetes Care · doi:10.2337/dc18-0050 · Cited by 63
Hypertension Contributes to Neuropathy in Patients With Type 1 Diabetes
Ponirakis, G., Petropoulos, I. N., Alam, U., Ferdousi, M., Asghar, O., Marshall, A. G., Azmi, S., Jeziorska, M., Mahfoud, Z. R., Boulton, A. J. M., et al. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz058 · Cited by 69
Self-citationDiabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus in Korea
Ko, S., & Cha, B. Y. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.1.6 · Cited by 67
Metadata
- Authors
- Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., & on behalf of the Toronto Diabetic Neuropathy Expert Group
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Mayo Clinic (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Adelaide (AU)
- I Department of Medicine, Semmelweis University, Budapest, Hungary;
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Rome Tor Vergata (IT)
- Eastern Virginia Medical School (US)
- University of Pavia (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tesfaye, Solomon
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-01
- Volume
- 33
- Issue
- 10
- Pages
- 2285-2293
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2945176
- OpenAlex
- W2113384757
- Cited by
- 2,690
- References
- 77
- Citations by year
- 2026: 180 · 2025: 190 · 2024: 221 · 2023: 199 · 2022: 226 · 2021: 235 · 2020: 220 · 2019: 175 · 2018: 189 · 2017: 155 · 2016: 157 · 2015: 127 · 2014: 151 · 2013: 102 · 2012: 94
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Eli Lilly and Company
- Louisiana State University
- Eastern Virginia Medical School
- Semmelweis Egyetem
- Gentofte Hospital
- University of Toronto
- Odense Universitetshospital
- Szegedi Tudományegyetem
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, diabetic autonomic neuropathy, diabetic neuropathic pain, neuropathy classification, diagnostic criteria, neuropathy treatment
- MeSH terms
- Diabetic Neuropathies, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.